Irvine California
Saturday-Sunday Closed
Researchers from the University of Cincinnati’s Department of Surgery, Division of Trauma and Critical Care, are now participating in a national clinical trial of an experimental drug to stop blood clot formation in victims of severe TBI. The drug known as Transexamic Acid (TXA) has the potential to save lives and improve outcomes.
Disclaimer: The information on headinjurylaw.com is provided for general informational purposes only, and may not reflect the current law in your city or state. No information contained in this post should be construed as legal advice from headinjurylaw.com or the individual author, nor is it intended to be a substitute for legal counsel on any subject matter. No reader of this post should act or refrain from acting on the basis of any information included in, or accessible through, this Post without seeking the appropriate legal or other professional advice on the particular facts and circumstances at issue from a lawyer licensed in the recipient’s state, country or other appropriate licensing jurisdiction.